Title and statement of responsibility area
Title proper
Veterinary Infectious Disease Organization - Official Opening
General material designation
- Graphic material
Parallel title
Other title information
Title statements of responsibility
Title notes
Level of description
Item
Reference code
Edition area
Edition statement
Edition statement of responsibility
Class of material specific details area
Statement of scale (cartographic)
Statement of projection (cartographic)
Statement of coordinates (cartographic)
Statement of scale (architectural)
Issuing jurisdiction and denomination (philatelic)
Dates of creation area
Date(s)
-
Oct. 1978 (Creation)
Physical description area
Physical description
1 photograph : b&w-drymounted ; 12.5 x 9.5 cm
1 negative : b&w ; 6 x 6 cm
Publisher's series area
Title proper of publisher's series
Parallel titles of publisher's series
Other title information of publisher's series
Statement of responsibility relating to publisher's series
Numbering within publisher's series
Note on publisher's series
Archival description area
Name of creator
Custodial history
Scope and content
R.W. Begg, University President, speaks from podium during the opening of the Vaccine and Infectious Disease Organization (VIDO). Dignitaries seated are (l to r): M. Moore; Herman Rolfes, Saskatchewan Minister of Continuing Education; and Dr. Chris Bigland, director of VIDO.
Bio/Historical Note: The Vaccine and Infectious Disease Organization (VIDO) is a research organization of the University of Saskatchewan that operates with financial support from the Government of Canada, the government of Saskatchewan, livestock industry councils and agencies, foundations and human and animal health companies. VIDO worked to find cures for common infectious diseases in cattle, swine and poultry. VIDO scientists carved out an international reputation for their pioneering work in the 1980's on vaccines aimed at combating shipping fever and a disease which produces pneumonia and arthritis in cattle. In addition to the 2,500,000 sq ft facility on campus, VIDO-InterVac also operates a 160-acre research station. The laboratory took on its current name, International Vaccine Centre (VIDO-InterVac), in March 2003. In October 2003 a large expansion was completed. In March 2004, VIDO received funding for the construction one of the world's largest and most advanced biosafety level 3 facilities, the International Vaccine Centre (InterVac), for research into emerging and reemerging human and animal diseases. In 2020, VIDO-InterVac began developing a vaccine for SARS-CoV-2 during the COVID-19 pandemic.
Notes area
Physical condition
Immediate source of acquisition
Arrangement
Language of material
Script of material
Location of originals
Availability of other formats
Restrictions on access
Terms governing use, reproduction, and publication
Photographer: Gibson
Other terms: Copyright: University of Saskatchewan
Finding aids
Associated materials
Accruals
Alternative identifier(s)
Standard number area
Standard number
Access points
Subject access points
Place access points
Name access points
- Begg, R.W. (Subject)
- Vaccine and Infectious Disease Organization (VIDO) (Subject)
- Biostar (Subject)
- Biowest (Subject)
- Star Biotech (Subject)
- Moore, M (Subject)
- Rolfes, Herman (Subject)
- Bigland, Dr. Chris (Subject)